Design of a trans protease lentiviral packaging system that produces high titer virus

<p>Abstract</p> <p>Background</p> <p>The structural and enzymatic proteins of the human immunodeficiency virus (HIV) are initially generated as two long polyproteins encoded from overlapping reading frames, one producing the structural proteins (Gag) and the second producing both structural and enzymatic proteins (Gag-Pol). The Gag to Gag-Pol ratio is critical for the proper assembly and maturation of viral particles. To minimize the risk of producing a replication competent lentivirus (RCL), we developed a "super-split" lentiviral packaging system in which Gag was separated from Pol with minimal loss of transducibility by supplying protease (PR) <it>in trans </it>independently of both Gag and Pol.</p> <p>Results</p> <p>In developing this "super-split" packaging system, we incorporated several new safety features that include removing the Gag/Gag-Pol frameshift, splitting the Gag, PR, and reverse transcriptase/integrase (RT/IN) functions onto separate plasmids, and greatly reducing the nucleotide sequence overlap between vector and Gag and between Gag and Pol. As part of the construction of this novel system, we used a truncated form of the accessory protein Vpr, which binds the P6 region of Gag, as a vehicle to deliver both PR and RT/IN as fusion proteins to the site of viral assembly and budding. We also replaced <it>wt </it>PR with a slightly less active T26S PR mutant in an effort to prevent premature processing and cytoxicity associated with <it>wt </it>PR. This novel "super-split" packaging system yielded lentiviral titers comparable to those generated by conventional lentiviral packaging where Gag-Pol is supplied intact (1.0 × 10⁶TU/ml, unconcentrated).</p> <p>Conclusion</p> <p>Here, we were able to create a true "split-function" lentiviral packaging system that has the potential to be used for gene therapy applications. This novel system incorporates many new safety features while maintaining high titers. In addition, because PR is supplied <it>in trans</it>, this unique system may also provide opportunities to examine viral protein processing and maturation.</p

High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing.

We have reported that of the 10 commonly used AAV serotype vectors, AAV6 is the most efficient in transducing primary human hematopoietic stem/progenitor cells (HSPCs). However, the transduction efficiency of the wild-type (WT) AAV6 vector varies greatly in HSPCs from different donors. Here we report two distinct strategies to further increase the transduction efficiency in HSPCs from donors that are transduced less efficiently with the WT AAV6 vectors. The first strategy involved modifications of the viral capsid proteins where specific surface-exposed tyrosine (Y) and threonine (T) residues were mutagenized to generate a triple-mutant (Y705 + Y731F + T492V) AAV6 vector. The second strategy involved the use of ex vivo transduction at high cell density. The combined use of these strategies resulted in transduction efficiency exceeding ~90% in HSPCs at significantly reduced vector doses. Our studies have significant implications in the optimal use of capsid-optimized AAV6 vectors in genome editing in HSPCs

Placenta Growth Factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

AbstractTumor growth and metastasis require concomitant growth of new blood vessels, which are stimulated by angiogenic factors, including vascular endothelial growth factor (VEGF), secreted by most tumors. Whereas the angiogenic property and molecular mechanisms of VEGF have been well studied, the biological function of its related homolog, placenta growth factor (PlGF), is poorly understood. Here we demonstrate that PlGF-1, an alternatively spliced isoform of the PlGF gene, antagonizes VEGF-induced angiogenesis when both factors are coexpressed in murine fibrosarcoma cells. Overexpression of PlGF-1 in VEGF-producing tumor cells results in the formation of PlGF-1/VEGF heterodimers and depletion of the majority of mouse VEGF homodimers. The heterodimeric form of PlGF-1/VEGF lacks the ability to induce angiogenesis in vitro and in vivo. Similarly, PlGF-1/VEGF fails to activate the VEGFR-2-mediated signaling pathways. Further, PlGF-1 inhibits the growth of a murine fibrosarcoma by approximately 90% when PlGF-1-expressing tumor cells are implanted in syngeneic mice. In contrast, overexpression of human VEGF in murine tumor cells causes accelerated and exponential growth of primary fibrosarcomas and early hepatic metastases. Our data demonstrate that PlGF-1, a member of the VEGF family, acts as a natural antagonist of VEGF when both factors are synthesized in the same population of cells. The underlying mechanism is due to the formation of functionally inactive heterodimers

Atypical BSE (BASE) Transmitted from Asymptomatic Aging Cattle to a Primate

BACKGROUND: Human variant Creutzfeldt-Jakob Disease (vCJD) results from foodborne transmission of prions from slaughtered cattle with classical Bovine Spongiform Encephalopathy (cBSE). Atypical forms of BSE, which remain mostly asymptomatic in aging cattle, were recently identified at slaughterhouses throughout Europe and North America, raising a question about human susceptibility to these new prion strains. METHODOLOGY/PRINCIPAL FINDINGS: Brain homogenates from cattle with classical BSE and atypical (BASE) infections were inoculated intracerebrally into cynomolgus monkeys (Macacca fascicularis), a non-human primate model previously demonstrated to be susceptible to the original strain of cBSE. The resulting diseases were compared in terms of clinical signs, histology and biochemistry of the abnormal prion protein (PrPres). The single monkey infected with BASE had a shorter survival, and a different clinical evolution, histopathology, and prion protein (PrPres) pattern than was observed for either classical BSE or vCJD-inoculated animals. Also, the biochemical signature of PrPres in the BASE-inoculated animal was found to have a higher proteinase K sensitivity of the octa-repeat region. We found the same biochemical signature in three of four human patients with sporadic CJD and an MM type 2 PrP genotype who lived in the same country as the infected bovine. CONCLUSION/SIGNIFICANCE: Our results point to a possibly higher degree of pathogenicity of BASE than classical BSE in primates and also raise a question about a possible link to one uncommon subset of cases of apparently sporadic CJD. Thus, despite the waning epidemic of classical BSE, the occurrence of atypical strains should temper the urge to relax measures currently in place to protect public health from accidental contamination by BSE-contaminated products

Tracking RPE transplants labeled by retroviral gene transfer with green fluorescent protein

PURPOSE. To determine whether human retinal pigment epithelium (RPE) can be modified by retroviral-mediated gene transfer and to monitor the human RPE cells in the subretinal space of living rabbits with scanning laser ophthalmoscopy (SLO). METHODS. Cultured human fetal retinal pigment epithelium (HFRPE) was exposed to green fluorescent protein (GFP)-transducing retroviral vectors, Moloney murine leukemia virus, and lentivirus. The cultured cells were followed by fluorescence microscopy. Suspensions of GFP-expressing HFRPE were transplanted into the subretinal space of pigmented rabbits, and the transplant sites were examined by SLO for fluorescence, including fluorescein and indocyanine green angiography. The rabbits were euthanatized at different times after transplantation, and the retinas were studied histologically. RESULTS. Retroviral gene transfer can introduce a foreign gene such as GFP into cultured HFRPE. Gene expression is maintained in cultured RPE for at least 3 months. The lentiviral vector traduced both nondividing and dividing cells; the Moloney vector only transduced the latter. GFPexpressing cells can be followed in the living retina. Their changes reflect the rejection response followed histologically. CONCLUSIONS. Cultured HFRPE could be transduced to express GFP for long periods of time by retroviral gene transfer. GFP allowed retinal transplants and gene expression to be monitored in vivo. These results provide a model for potential ex vivo gene therapy in the subretinal space. (Invest Ophthalmol Vis Sci. 1999;40:2141-2146 T he green fluorescent protein (GFP) gene has been derived from the bioluminescent jelly fish, Aequorin victoria. This protein fluoresces green light when excited by blue or ultraviolet light. The cloning of this gene and the demonstration that it can be expressed in other organisms provides a useful way to select and follow cells exhibiting specific gene expression, [1][2][3] especially in a transparent structure such as the eye. 4 We have used replication-deficient retroviruses to transduce cultured human fetal retinal pigment epithelium (HFRPE) with the gene encoding GFP. We followed the expression of this protein in vitro by fluorescence microscopy and in vivo after transplantation to the subretinal space of rabbits by scanning laser ophthalmoscopy (SLO). We demonstrated that retroviral transduction is effective, stable, and long-lasting in vitro. It allows transplanted RPE to be monitored in the subretinal space and provides a noninvasive indicator of the time course of rejection. An abstract on some of this research has been published. 5 METHODS Culturing of RPE Donor tissue was obtained from human fetal eyes, 16 to 20 weeks of gestational age. Informed consent was obtained for the use of this tissue before abortion and institutional approval was granted through an agreement between Albert Einstein College of Medicine, the source of the tissue, and Columbia University. The eye bulbs were washed externally with 70% alcohol and then with phosphate-buffered saline (PBS). The eyes were put into our standard RPE culture medium, Dulbecco&apos;s modified Eagle&apos;s medium with 4.5 g/l glucose supplemented with 20% fetal calf serum (Hyclone, Logan, Utah), 2 mM L-glutamine and penicillin (50 unit/ml)/streptomycin (50 mg/ml) (Gibco, Grand Island, NY). The anterior segment with lens, vitreous, and neural retina was removed. The posterior segment was sliced into quadrants, and RPE patches were separated gently from Bruch&apos;s membrane and choroid, using fine forceps and microscopic viewing. A distinct cleavage plane is identifiable between the taut monolayer patch of RPE and the adjacent choroid so that an isolated sheet of RPE can be pulled off. Each sheet was placed in a separate culture plate. The edges of the sheet were pressed onto the surface of the plate with the tip of a 26-gauge needle. The cultures were maintained at 37°C in an incubator with a humidified atmosphere of 95% air/5% CO 2 , fed every 3 to 4 days, and examined almost daily. To obtain cell suspensions, we washed the cells with PBS three times and exposed them to 2.5% trypsin in Hank&apos;s solution with EDTA without Ca and Mg (Gibco) for 10 minutes at 37°C. The monolayer was triturated into single cells or clusters of cells by repeated pipetting. The concentration of cells in a suspension was determined with a hemocytometer. The cells were either used for transplantation or subcultured. Preparation of Virus Stocks For the Moloney vector a DNA construct was generated consisting of the humanized red-shifted GFP (EGFP) under the translational control of an Internal Ribosome Entry Site from the encephalomyocarditis virus (EMCV-IRES), flanked by long terminal repeat (LTR) of Moloney murine leukemia virus (MoMLV). These viral sequences include the two LTRs, and the two sites for initiation of viral DNA synthesis (the primer binding site for initiation of minus-strand DNA synthesis and the polypurine tract for initiation of plus-strand synthesis). They also include the RNA packaging signal, termed the Psi region, near the 5Ј end of the genome. The construct was then introduced into AM 12 packaging cells that express the viral proteins required for the assembly of a virion particle. The viral RNA was transcribed from a transfected plasmid and selectively packaged into viral particles produced by the packaging cells. The virions were collected from the culture medium, purified, and concentrated as needed. To transduce the gene to RPE, the virus was applied directly to the target cells. Typical titers were 10 5 to 10 6 infectious units/ml. For the lentiviral vector, human immunodeficiency virus (HIV)-based preparations were generated by cotransfection of human kidney-derived 293T cells by three plasmids using the CaPO 4 method. 6 The packaging construct contained the cytomegalovirus promoter and the insulin polyadenylation signal to express all the viral proteins in trans, except the envelope and Vpu. 6 The second plasmid provided a vector with all the cis-acting elements that allow transfer and integration into the target cell. In this transducing vector, an expression cassette with the Rev responsive element (RRE) and the cytomegalovirus promoter are used to direct the expression of GFP. 6 The third plasmid provides the envelope protein from the vesicular stomatitis virus glycoprotein to enhance the viral stability and the range of possible target cells. 6 The titer of the HIV vector was determined by a fluorescent activated cell sorter (FACStar plus; Becton Dickinson, Mountain View, CA) scanning GFPtransduced cells. The lentiviral titers were determined by infection of 293 cells seeded in 6-well plates at 1 ϫ 10 5 cells per well the day before infection with serial dilution of concentrated viral stock in the presence of 8 g/ml of polybrene (Aldrich, Milwaukee, WI). After overnight incubation, the cell culture medium was changed, and the cells were incubated further for 2 days. GFP fluorescent cells were identified by fluorescent microscopy and/or the FACS. Typical titers were 10 8 to 10 9 infectious units/ml. In Vitro Transfection For viral transduction, primary cultures were dissociated into cell suspensions and subcultured in 6-well plates containing approximately 10 5 cells/well. This promotes cell division and augments the total number of cells available. After 24 hours in standard RPE culture medium, the medium was replaced with the viral solution, consisting of Hepes buffer with 20% fetal calf serum, 2 mM L-glutamine, 8 g/ml polybrene, and a viral titer of 10 5 to 10 7 infectious units/ml before concentration. This solution was replaced with fresh viral solution every 6 hours for 48 hours. After 48 hours, this solution was replaced with standard RPE medium, and the cultures were allowed to reach confluency, examined by fluorescence microscopy, and used for transplantation. For comparing viral transduction of stationary versus dividing cells, the virus was introduced directly into the primary culture containing the original patch of heavily pigmented cells, surrounded by an expanding population of dividing cells, the size of which depended on the age of the culture. To determine the fraction of cells expressing GFP, the number of GFP fluorescent cells and the total number of cells were counted within defined areas, 0.4 ϫ 0.8 mm, in the culture plate. All cells that showed green fluorescence were considered to be expressing GFP. We examined cells in the same areas in three different parts of each culture plate, the patch that contained stationary pigmented cells only, the edge of the patch where cells were migrating and entering into cell division, and the growing margin of the culture, which contained many fewer pigmented, dividing cells. We measured these same areas repeatedly in 15 different cultures, weekly for 3 weeks; 5 cultures were measured for 6 weeks, and 1 culture for 3 months. In one case, we dissociated a primary culture that we had examined for 3 months and replated the cells to follow GFP fluorescence after repeated cell division. Transplantation Thirty adult pigmented rabbits received subretinal transplants placed within small bleb detachments just below the myelinated region of the optic nerve. Bleb detachments also were formed in two rabbits with saline alone. Each animal was anesthetized with sodium pentobarbital (25 mg/kg, intramuscularly) and xylazine (10 mg/kg, intramuscularly). The pupil was dilated with 2% cyclopentolate and 2.5% neosynephrine. A lid speculum was used to keep the eye open and occasionally a canthotomy also was performed. A conjunctival flap was formed at the limbal region, and a sclerotomy made approximately 3 mm behind the limbus. A glass pipette with a tip diameter of 80 to 100 m, connected to a 1-ml syringe and filled with balanced salt solution (BSS) was introduced into the vitreal cavity. Using a corneal contact lens and a surgical microscope the pipette was directed to the retinal surface. At the surface of the retina a jet stream of BSS was slowly injected through the neural retina to produce a small bleb detachment. A second similar pipette was used to suck up a pellet of a concentrated solution of GFP-expressing HFRPE cells from the bottom of an Eppendorf tube. The cell suspension was obtained by rinsing a culture three times with PBS and then dissociating the cells with 0.05% trypsin for 5 minutes at 37°C. The cells were washed with PBS and centrifuged. The pellet was resuspended in 0.5 ml BSS, put into an Eppendorf tube, centrifuged at 1000 rpm for 2 minutes, and stored at 4°C. The cells were used within 2 hours of preparation. Approximately 10 l of cell suspension containing approximately 10 5 cells was introduced into the bleb detachment, either through the same retinotomy or through a second one; the latter method was preferable because it minimized any reflux of transplant cells into the vitreous. A small air bubble separated the suspension from the BSS solution in the pipette. The bubble also was introduced into the bleb detachment to prevent efflux of the transplant cells into the vitreous. The air bubble disappeared in 24 hours. After the pipette was removed, the sclera and conjunctiva were sutured with 9-0 nylon. Reports IOVS, August 1999, Vol. 40, No. 9 Downloaded from iovs.arvojournals.org on 06/30/2019 Retinal Examination Rabbits were examined 1 day after surgery, weekly for 8 weeks, and monthly thereafter by indirect ophthalmoscopy, SLO (Rodenstock, Munich, Germany) and sometimes by contact lens biomicroscopy. The SLO provided infrared (780 nmoles), He-Neon red (633 nmoles), argon green (514 nmoles), and blue (488 nmoles) illumination. We examined retinal fluorescence with argon blue illumination and a fluorescein barrier filter. We graded the fluorescence using a scale of 0 to 4 (0, no fluorescence,; 1, just detectable; 2, distinct; 3, strong; 4, very strong). Fluorescein and indocyanine green (ICG) angiography were performed simultaneously with an SLO double-detection system that was able to detect fluorescein and ICG simultaneously. Angiography was performed August 1999, Vol. 40, No. 9 Reports IOVS, weekly for 2 to 3 weeks and monthly thereafter. The dyes were injected into an ear vein in one bolus containing 0.2 ml fluorescein (100 mg/ml) and 0.7 ml ICG (4.2 mg/ml). Histology After the rabbit was euthanatized, the eyes were enucleated, punctured with a 20 gauge needle at several places near the limbus to facilitate diffusion, and immersed in a solution of either 3% glutaraldehyde or 4% paraformaldehyde in PBS at pH 7.2 for 24 to 48 hours at 4°C. The eyes then were washed with PBS and dissected with the aid of a microscope. The transplant site was located, examined, and cut out with its orientation marked so that the site could be reached with minimal sectioning. For Epon embedding, glutaraldehyde-fixed segments were postfixed with 1% osmic acid and dehydrated with ethanol. Sections were cut semi-serially and examined by light microscopy; selected areas were examined by electron microscopy. For cryosectioning paraformaldehyde-fixed segments were immersed in OCT compound (Miles, Elkhart, IN) and frozen by dry ice. Cryosectioning was performed on a Leica 1850 cryotome (Leica Instruments, Nusslach, Germany). Sections were mounted on gelatinized glass slides with fluoromount-G. GFP polyclonal antibody (diluted 1:100; Clontech Laboratories, Palo Alto, CA) was used for immunocytochemistry. Cultured RPE cells not exposed to the virus were used as a negative control. RESULTS GFP fluorescence was detectable in cultured HFRPE within 5 days after being exposed to the retrovirus. The MoMLV only transduced dividing cells that occurred along the edge of patch cultures spreading out centrifugally over the culture plate. 7 The lentivirus transduced both stationary and dividing cells

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

BACKGROUND We recently reported that peroxisome proliferator‐activated receptor γ agonists target chronic myeloid leukemia (CML) quiescent stem cells in vitro by decreasing transcription of STAT5. Here in the ACTIM phase 2 clinical trial, we asked whether pioglitazone add‐on therapy to imatinib would impact CML residual disease, as assessed by BCR‐ABL1 transcript quantification. METHODS CML patients were eligible if treated with imatinib for at least 2 years at a stable daily dose, having yielded major molecular response (MMR) but not having achieved molecular response 4.5 (MR4.5) defined by BCR‐ABL1/ABL1 IS RNA levels ≤ 0.0032%. After inclusion, patients started pioglitazone at a dosage of 30 to 45 mg/day in addition to imatinib. The primary objective was to evaluate the cumulative incidence of patients having progressed from MMR to MR4.5 over 12 months. RESULTS Twenty‐four patients were included (age range, 24‐79 years). No pharmacological interaction was observed between the drugs. The main adverse events were weight gain in 12 patients and a mean decrease of 0.4 g/dL in hemoglobin concentration. The cumulative incidence of MR4.5 was 56% (95% confidence interval, 37%‐76%) by 12 months, despite a wide range of therapy duration (1.9‐15.5 months), and 88% of 17 evaluable patients who were still on imatinib reached MR4.5 by 48 months. The cumulative incidence of MMR to MR4.5 spontaneous conversions over 12 months was estimated to be 23% with imatinib alone in a parallel cohort of patients. CONCLUSION Pioglitazone in combination with imatinib was well tolerated and yielded a favorable 56% rate. These results provide a proof of concept needing confirmation within a randomized clinical trial (EudraCT 2009‐011675‐79). Cancer 2017;123:1791–1799. © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy

Human genetic diseases have been successfully corrected by integration of functional copies of the defective genes into human cells, but in some cases integration of therapeutic vectors has activated proto-oncogenes and contributed to leukemia. For this reason, extensive efforts have focused on analyzing integration site populations from patient samples, but the most commonly used methods for recovering newly integrated DNA suffer from severe recovery biases. Here, we show that a new method based on phage Mu transposition in vitro allows convenient and consistent recovery of integration site sequences in a form that can be analyzed directly using DNA barcoding and pyrosequencing. The method also allows simple estimation of the relative abundance of gene-modified cells from human gene therapy subjects, which has previously been lacking but is crucial for detecting expansion of cell clones that may be a prelude to adverse events

Direct Binding of pRb/E2F-2 to GATA-1 Regulates Maturation and Terminal Cell Division during Erythropoiesis

Cell differentiation is often coupled with cell cycle arrest. Here, we show that direct binding of the erythroid transcription factor GATA-1 to the retinoblastoma protein and the pRb/E2F transcription factor complex is critical for red blood cell formation